- Bi-weekly epirubicin, etoposide and low-dose dexamethasone for hormone-refractory prostate cancer. Odrazka, K., Vaculikova, M., Petera, J., Moravek, P., Prosvic, P., Zoul, Z., Rydel, L., Brodak, M., Veselsky, Z., Louda, M., Simakova, E. International journal of urology : official journal of the Japanese Urological Association. (2003)